Results 151 to 160 of about 96,578 (258)

Cardioprotective effects of semaglutide on isolated human ventricular myocardium

European Journal of Heart Failure, EarlyView.
Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer, Maria J. Baier, Philipp Hegner, Tilman Zschiedrich, David Lukas, Matthias Wolf, Christian Le Phu, Vanessa Lutz, Katja Evert, Kostiantyn Kozakov, Jing Li, Andreas Holzamer, Lars S. Maier, Zdenek Provaznik, Donald M. Bers, Stefan Wagner, Julian Mustroph   +16 more
wiley   +1 more source

Poor sleep quality was associated with increased plasma aldosterone concentration in community dwellers, a cross-sectional study. [PDF]

Sci Rep
Li X, Heizhati M, Li M, Yao L, Wu T, Yang W, Gan L, Wang H, Liu M, Maitituersun A, Lin M, Hong J, Li N.   +12 more
europepmc   +1 more source

The isolation of a substance very closely resembling the 18‐monoacetate of D‐aldosterone from the venous blood of activated muscle and from contracting muscle

, 1969
Mary F. Lockett, R.W. Retallack
openalex   +2 more sources

THE EFFECT OF ACTH, RENIN, ANGIOTENSIN II, AND VARIOUS PRECURSORS ON BIOSYNTHESIS OF ALDOSTERONE BY ADRENAL SLICES [PDF]

, 1962
Norman M. Kaplan, Frederic C. Bartter
openalex   +1 more source

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death across cardio‐kidney‐metabolic diseases: A meta‐analysis of randomized clinical trials

European Journal of Heart Failure, EarlyView.
Abstract Aims Sudden cardiac death (SCD) is a prevalent cause of mortality among patients with cardio‐kidney‐metabolic (CKM) diseases. Mineralocorticoid receptor antagonists (MRAs) reduce the risk of SCD in patients with left ventricular dysfunction, but it is unclear if similar effects are expected across different CKM risk populations irrespective of
Pedro Marques, Faiez Zannad, João Pedro Ferreira   +2 more
wiley   +1 more source

MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism. [PDF]

J Transl Med
Li X, Luo M, Zeng Y, Zhang R, Lin X, Du Y, Zhao W, Feng Q, Wu M, Zhang J, Guo L, Wu P, Yang C, Cai F, Wang Y, Hu Y, Wang H, Liu N, Xu L, Guan M.   +19 more
europepmc   +1 more source

Aldosterone and 17-hydroxycorticosteroid Excretion Following Ramstedt's Operation

, 1965
William Hamilton
openalex   +1 more source

Aldosterone excretion in normal children and in children with adrenal hyperplasia. [PDF]

, 1966
Maria I. New, Barbara Stoler Miller, Ralph E. Peterson   +2 more
openalex   +1 more source

Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

European Journal of Heart Failure, EarlyView.
Heart failure (HF) with supranormal ejection fraction (HFsnEF) is an unnoticed but emerging entity in HF. This study showed that HFsnEF carries a similarly increased cardiovascular risk as HF with reduced ejection fraction (HFrEF) and distinct structural and proteomic characteristics from HFrEF, warranting a further comprehensive understanding and ...
Yasuhiko Sakata, Kotaro Nochioka, Satoshi Yasuda, Koichi Ishida, Takashi Shiroto, Jun Takahashi, Shintaro Kasahara, Ruri Abe, Shinsuke Yamanaka, Takahide Fujihashi, Hideka Hayashi, Shintaro Kato, Katsunori Horii, Kanako Teramoto, Tsutomu Tomita, Satoshi Miyata, Koichiro Sugimura, Iwao Waga, Masao Nagasaki, Hiroaki Shimokawa   +19 more
wiley   +1 more source

Clinical significance of parathyroid hormone in mineral and glucose metabolism disorders among patients with primary aldosteronism. [PDF]

SAGE Open Med
Sun Z, Liu W.
europepmc   +1 more source